Details of the Drug

General Information of Drug (ID: DMZB0C3)

• Drug Name: (Carboxyhydroxyamino)Ethanoic Acid
• Synonyms: AC1NRBMN; N-(carboxymethyl)-N-hydroxycarbamate

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 135.08
  Logarithm of the Partition Coefficient (xlogp); -1.1
  Rotatable Bond Count (rotbonds); 2
  Hydrogen Bond Donor Count (hbonddonor); 3
  Hydrogen Bond Acceptor Count (hbondacc); 5
• Chemical Identifiers:
  Formula: C3H5NO5
  IUPAC Name: 2-[carboxy(hydroxy)amino]acetic acid
  Canonical SMILES: C(C(=O)O)N(C(=O)O)O
  InChI: InChI=1S/C3H5NO5/c5-2(6)1-4(9)3(7)8/h9H,1H2,(H,5,6)(H,7,8)
  InChIKey: LJSQPIOQKDFEKE-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 4633094
  DrugBank ID: DB02954
  TTD ID: D00HWD

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Plasmodium Adenylosuccinate synthetase (Malaria Adss)	TTYQ4AE	PURA_PLAFA	Inhibitor	[1]

References

• [1] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.